negative impacts of glp 1 The expanding role GLP-1 receptor agonists: a narrative review of current evidence and future directions Before you blame the medication,

This review synthesizes evidence across key mechanistic domains, including endothelial dysfunction, inflammatory signaling, oxidative stress pathways, plaque biology, extracellular matrix remodeling, and immune-cell modulation

Prescription GLP-1 receptor agonists may be indicated for adults with type 2 diabetes not meeting glycemic targets, those with established cardiovascular disease or chronic kidney disease, or individuals with obesity and weight-related complications when lifestyle interventions prove insufficient

No, semaglutide does not increase UTI risk based on FDA prescribing information and clinical trials